KABACAOGLU, Derya, CIECIELSKI, Katrin J., RUESS, Dietrich Alexander und ALGÜL, Hana, 2020. Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options. Freiburg: Universität.
Elsevier - Harvard (with titles)Kabacaoglu, D., Ciecielski, K.J., Ruess, D.A., Algül, H., 2020. Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options. Universität, Freiburg. https://doi.org/10.3389/fimmu.2018.01878
American Psychological Association 7th editionKabacaoglu, D., Ciecielski, K. J., Ruess, D. A., & Algül, H. (ca. 2020). Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options [Cd]. Universität. https://doi.org/10.3389/fimmu.2018.01878
Springer - Basic (author-date)Kabacaoglu D, Ciecielski KJ, Ruess DA, Algül H (2020) Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Kabacaoglu, Derya/ Ciecielski, Katrin J./ Ruess, Dietrich Alexander/ Algül, Hana, Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options, Freiburg 2020.